nach oben

Erschienen in:

18.12.2018 | Editorial

Low-dose radiotherapy: Mayday, mayday. We’ve been hit!

verfasst von: Prof. Dr. med. Oliver J. Ott, Prof. Dr. Oliver Micke, PD Dr. Ralph Mücke, Prof. Dr. Marcus Niewald, Prof. Dr. Franz Rödel, Prof. Dr. Ulrich Schäfer, Prof. Dr. M. H. Seegenschmiedt, Prof. Dr. Meritxell Arenas, PD Dr. Benjamin Frey, Prof. Dr. Udo S. Gaipl, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD)

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Excerpt

For more than a hundred years the ship cruised through the sea totally unfazed, mighty and big. Over the decades, tens of thousands became acquainted with the luxury and wellness on board. Suddenly, two small icebergs appeared on the horizon … …

Kriz J, Seegenschmiedt HM, Bartels A et al (2018) Updated strategies in the treatment of benign diseases—a patterns of care study of the german cooperative group on benign diseases. Adv Radiat Oncol 3:240–244CrossRefPubMedPubMedCentral

Kaltenborn A, Carl UM, Hinsche T et al (2017) Low-dose external beam radiotherapy for greater trochanteric pain syndrome: target volume definition and treatment outcome. Strahlenther Onkol 193:260–268CrossRefPubMed

Prokein B, Holtmann H, Hautmann MG et al (2017) Radiotherapy of painful heel spur with two fractionation regimens: results of a randomized multicenter trial after 48 weeks’ follow-up. Strahlenther Onkol 193:483–490CrossRefPubMed

Dietzel CT, Schafer C, Vordermark D (2017) Successful treatment of chronic recurrent multifocal osteomyelitis using low-dose radiotherapy : a case report. Strahlenther Onkol 193:229–233CrossRefPubMed

Niewald M, Seegenschmiedt MH, Micke O et al (2012) Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months’ follow-up. Int J Radiat Oncol Biol Phys 84:e455–e462CrossRefPubMed

Mahler EAM, Minten MJ, Leseman-Hoogenboom MM et al (2018) Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2018-214104 CrossRefPubMed

Minten MJM, Leseman-Hoogenboom MM, Kloppenburg M et al (2018) Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial. Osteoarthritis Cartilage 26:1283–1290CrossRefPubMed

Mücke R, Micke O, Seegenschmiedt MH, Schäfer U (2018) Leitlinen in der Strahlentherapie: Strahlentherapie gutartiger Erkrankungen – Fachgruppenspezifische evidenzbasierte S2e-Leitlinie der Deutschen Gesellschaft für Radioonkologie (DEGRO)

Micke O, Ugrak E, Bartmann S et al (2018) Radiotherapy for calcaneodynia, achillodynia, painful gonarthrosis, bursitis trochanterica, and painful shoulder syndrome—Early and late results of a prospective clinical quality assessment. Radiat Oncol 13:71CrossRefPubMedPubMedCentral

10.

Rödel F, Frey B, Manda K et al (2012) Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x‑irradiation. Front Oncol 2:120CrossRefPubMedPubMedCentral

11.

Deloch L, Derer A, Hueber AJ et al (2018) Low-dose radiotherapy ameliorates advanced arthritis in hTNF-alpha tg mice by particularly positively impacting on bone metabolism. Front Immunol 9:1834CrossRefPubMedPubMedCentral

12.

Ott OJ, Hertel S, Gaipl US et al (2014) The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results. Strahlenther Onkol 190:293–297CrossRefPubMed

13.

Neumann E, Junker S, Schett G et al (2016) Adipokines in bone disease. Nat Rev Rheumatol 12:296–302CrossRefPubMed

14.

Mücke R, Micke O, Reichl B et al (2007) Demographic, clinical and treatment related predictors for event-free probability following low-dose radiotherapy for painful heel spurs—a retrospective multicenter study of 502 patients. Acta Oncol 46:239–246CrossRef

Titel: Low-dose radiotherapy: Mayday, mayday. We’ve been hit!
verfasst von: Prof. Dr. med. Oliver J. Ott
Prof. Dr. Oliver Micke
PD Dr. Ralph Mücke
Prof. Dr. Marcus Niewald
Prof. Dr. Franz Rödel
Prof. Dr. Ulrich Schäfer
Prof. Dr. M. H. Seegenschmiedt
Prof. Dr. Meritxell Arenas
PD Dr. Benjamin Frey
Prof. Dr. Udo S. Gaipl
German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD)
Publikationsdatum: 18.12.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 4/2019
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-018-1412-1

Neu im Fachgebiet Onkologie

10.04.2024 | PSA-Screening | Nachrichten

Springer Medizin

Low-dose radiotherapy: Mayday, mayday. We’ve been hit!

Excerpt

Neu im Fachgebiet Onkologie

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Das Ende der vollständigen axillären Lymphknotendissektion

Senkt Schlafapnoe das Überleben bei Lungenkrebs?

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study

A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences

Management immunologischer Nebenwirkungen von Patienten, die mit Immun-Checkpoint-Inhibitoren behandelt werden: ASCO Clinical Practice Guideline Summary

Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials

Reply to the letter to the editor “Comment to ‘Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials’”

Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer

Neu im Fachgebiet Onkologie

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Das Ende der vollständigen axillären Lymphknotendissektion

Senkt Schlafapnoe das Überleben bei Lungenkrebs?

Update Onkologie